GGrantIndex
Sort

16,300 grants matching fatty liver disease

Characterization of novel insulin resistance genes by gene editing, high-throughput phenotyping and in vivo studies

$648,352
Joshua Wiley Knowles · Stanford University · R01 · FY2020 · DK

Genetic determinants of Bacteroides vulgatus colonization fitness and host inflammatory responses

$648,179
John F Rawls · Duke University · R01 · FY2025 · DK

Carotid plaque characteristics by MRI in AIM-HIGH

$648,146
Xue-Qiao Zhao · University Of Washington · R01 · FY2011 · HL

Research Project 1 - Hepatocellular Genetic Epidemiology of Fatty Liver Disease in Hispanics

$648,026
Joanne E Curran · University Of Texas Rio Grande Valley · U54 · FY2025 · HG

Surgical or Medical Treatment for Pediatric Type 2 Diabetes (ST2OMP)

$647,956
Michael A Helmrath · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · DK

Predictors of Youth-Onset Type 2 Diabetes: UAB Clinical Center

$647,882
Barbara A. Gower · University Of Alabama At Birmingham · U01 · FY2025 · DK

Integrative Molecular Profiling of Human Pancreatic Cancer

$647,802
Syed Perwez Hussain · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

ER stress and UPR in non-alcoholic steatohepatitis and hepatocellular carcinoma

$647,740
Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · CA

Shape up! Kids

$647,631
John Alan Shepherd · University Of Hawaii At Manoa · R01 · FY2020 · DK

Risk Stratification for and Early Detection of Liver Cancer

$647,515
Fasiha Kanwal · Baylor College Of Medicine · U01 · FY2022 · CA

Development of quantitative bone marrow magnetic resonance imaging biomarkers to assess efficacy of novel molecularly targeted agents for myelofibrosis

$647,398
Brian D. Ross · University Of Michigan At Ann Arbor · R01 · FY2025 · CA

Blood TG clearance and vascular biology

$647,320
Ira Jay Goldberg · New York University D/B/A Nyu Long Island School Of Medicine · P01 · FY2024 · HL

Targeting hepatic mitochondrial oxidation to treat NAFLD, NASH and type 2 diabetes

$647,207
Gerald I Shulman · Yale University · R01 · FY2025 · DK

Biochemistry Core

$647,039
Duck-Yeon Lee · National Heart, Lung, And Blood Institute · ZIC · FY2025 · HL

Confounder-Corrected Quantitative MRI Biomarkers of Hepatic

$647,003
Scott B. Reeder · University Of Wisconsin-Madison · R01 · FY2017 · DK

Global HIV Drug Therapies and Mitochondrial Complications and Mechanisms

$646,995
Mariana Gerschenson · University Of Hawaii At Manoa · R01 · FY2010 · AI

Molecular mechanisms underlying the genetic association between PPP1R3B and hepatic steatosis

$646,698
Daniel James Rader · University Of Pennsylvania · R01 · FY2019 · DK

Carotid plaque characteristics by MRI in AIM-HIGH

$646,655
Xue-Qiao Zhao · University Of Washington · R01 · FY2012 · HL

Development of P2Y Receptor Ligands

$646,531
Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK

Novel IP6K1 inhibitors for treatment of NAFLD/NASH

$646,254
Xiaodong Wang · Univ Of North Carolina Chapel Hill · R01 · FY2024 · DK

Non Alcoholic Steatohepatitis Clinical Research Network

$645,943
Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2021 · DK

Hepatic Rap1a in cholesterol homeostasis

$645,814
Lale Ozcan · Columbia University Health Sciences · R01 · FY2025 · HL

Hepatic Rap1a in cholesterol homeostasis

$645,814
Lale Ozcan · Columbia University Health Sciences · R01 · FY2023 · HL

Extracellular Vesicle-Based Digital Scoring Assay for Detecting Early-stage Hepatocellular Carcinoma

$645,686
Yazhen Zhu · University Of California Los Angeles · R01 · FY2025 · CA

Extracellular Vesicle-Based Digital Scoring Assay for Detecting Early-stage Hepatocellular Carcinoma

$645,686
Yazhen Zhu · University Of California Los Angeles · R01 · FY2022 · CA